Cytosorbents
CTSO
#11211
Rank
A$1.57 M
Marketcap
A$0.50
Share price
0.03%
Change (1 day)
-64.84%
Change (1 year)

Cytosorbents (CTSO) - Cash on Hand

Cash on Hand as of June 2026 : A$6.33 Million

According to Cytosorbents's latest financial reports the company has A$6.33 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Cytosorbents - Cash on Hand chart (from 2005 to 2026)

Cash on Hand by year

Year Cash on Hand Change
2025-12-31A$9.32 M76.92%
2024-12-31A$5.27 M-74.58%
2023-12-31A$20.74 M-36.26%
2022-12-31A$32.54 M-54.75%
2021-12-31A$71.91 M-22.57%
2020-12-31A$92.88 M431.64%
2019-12-31A$17.47 M-44.98%
2018-12-31A$31.75 M43.11%
2017-12-31A$22.18 M204.92%
2016-12-31A$7.27 M-29.4%
2015-12-31A$10.3 M52%
2014-12-31A$6.78 M177.08%
2013-12-31A$2.44 M47.07%
2012-12-31A$1.66 M43.79%
2011-12-31A$1.15 M11.36%
2010-12-31A$1.03 M-41.49%
2009-12-31A$1.77 M-57.5%
2008-12-31A$4.17 M1626.82%
2007-12-31A$0.24 M-93.36%
2006-12-31A$3.64 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Boston Scientific
BSX
A$2.08 B 32,825.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Hologic
HOLX
A$3.39 B 53,484.86%๐Ÿ‡บ๐Ÿ‡ธ USA
Meridian Bioscience
VIVO.defunct
A$0.11 B 1,745.75%๐Ÿ‡บ๐Ÿ‡ธ USA